Sharescart Research Club logo

Classic Biotech Overview

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Classic Biotech Key Financials

Market Cap ₹- Cr.

Stock P/E

P/B -

Current Price ₹0

Book Value ₹ 0

Face Value 10

52W High ₹0

Dividend Yield -%

52W Low ₹ 0

Classic Biotech Share Price

| |

Volume
Price

Classic Biotech Quarterly Price

Show Value Show %

Classic Biotech Peer Comparison

Classic Biotech Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Classic Biotech Profit & Loss

#(Fig in Cr.) TTM
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 0% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average NA% NA% NA% NA%
ROCE Average NA% NA% NA% NA%

Classic Biotech Balance Sheet

#(Fig in Cr.)
Shareholder's Funds
Minority's Interest
Borrowings
Other Non-Current Liabilities
Total Current Liabilities
Total Liabilities
Fixed Assets
Other Non-Current Assets
Total Current Assets
Total Assets

Classic Biotech Cash Flow

#(Fig in Cr.)
Opening Cash & Cash Equivalents
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activities
Net Cash Inflow / Outflow
Closing Cash & Cash Equivalent

Classic Biotech Ratios

#
Earnings Per Share (Rs)
CEPS(Rs)
DPS(Rs)
Book NAV/Share(Rs)
Core EBITDA Margin(%)
EBIT Margin(%)
Pre Tax Margin(%)
PAT Margin (%)
Cash Profit Margin (%)
ROA(%)
ROE(%)
ROCE(%)
Receivable days
Inventory Days
Payable days
PER(x)
Price/Book(x)
Dividend Yield(%)
EV/Net Sales(x)
EV/Core EBITDA(x)
Net Sales Growth(%)
EBIT Growth(%)
PAT Growth(%)
EPS Growth(%)
Debt/Equity(x)
Current Ratio(x)
Quick Ratio(x)
Interest Cover(x)
Total Debt/Mcap(x)

Classic Biotech Shareholding Pattern

# Dec 2006 Mar 2007 Jun 2007 Sep 2007 Dec 2007 Jun 2008 Sep 2008 Dec 2008 Mar 2009 Jun 2009
Promoter 8.3 8.3 8.3 8.3 8.3 8.3 8.3 8.3 8.3 8.3
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 91.7 91.7 91.7 91.7 91.7 91.7 91.7 91.7 91.7 91.7
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Classic Biotech News

Classic Biotech Pros & Cons

Pros

Cons

  • Promoter holding is low: 8.3%.
  • Company has a low return on equity of 0% over the last 3 years.
whatsapp